ALL Ultrasound Predicts the Success of ACL Repair? (ALL_US)

September 17, 2021 updated by: Adrien Schwitzguebel

Does Anterolateral Ligament Ultrasound Influences the Return-to-play After Anterior Cruciate Ligament Rupture? Survival Analysis

This case series evaluates whether patients with an anterior cruciate ligament (ACL) repair have better outcome if the anterolateral ligament (ALL) was repaired or not considering the ultrasound (US) pre-surgical recommendation.

Study Overview

Detailed Description

In this case series, the surgeon will decide which patient will have ACL only or ACL and ALL surgery on the basis on multiple parameters. All patient will undergo detailed pre-clinical evaluation, including an ultrasonographic evaluation of the integrity of the ALL.

Two subgroups will be compared for the primary outcome (International Knee Documentation Committee score at 8 months of follow-up). In subgroup 1, the surgeon will follow the ultrasonographic evaluation of the ALL considering the ALL repair (i.e. : ALL intact on the ultrasound, ACL repair only; ALL broken on ultrasound; ACL and ALL repair). In subgroup 2, the surgeon will not follow the ultrasonographic evaluation of the ALL considering the ALL repair.

Secondary outcomes of interest will be evaluated with multivariate regression analysis.

Sample size calculation:

The chosen parameter of interest for the primary outcome evaluation is a continuous response variable (IKDC score) from two independent subgroups (ultrasonographic evaluation of the ALL followed or not for the surgical repair), considering a ratio of 1:3 between the two subgroups. In a previous study (AJSM Sonnery-Cottet 2017) the response within each subject group was normally distributed with standard deviation 13.1. If the true difference between the group means is the published minimal clinically important difference of 9 (AJSM Nwachukwu 2017), we will need to study 30 experimental subjects and 90 control subjects to be able to reject the null hypothesis that the population means of the experimental and control groups are equal with probability (power) 0.9. The Type I error probability associated with this test of this null hypothesis is 0.05.

Study Type

Observational

Enrollment (Anticipated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

ACL rupture

Description

Inclusion Criteria:

  • Patients with an ACL rupture and pre-surgical ultrasound evaluation

Exclusion Criteria:

  • Sedentary patient without sports activities
  • Prior ACL rupture of the same knee
  • Posterior cruciate ligament rupture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ACL rupture without indication for ALL surgery
Patients with an ACL rupture undergoing surgical repair of the ACL only
Surgical repair of the ACL using semitendinous autograft
ACL rupture with indication for ALL surgery
Patients with an ACL rupture undergoing surgical repair of the ACL and the ALL
Surgical repair of the ACL using semitendinous autograft, and surgical repair of the ALL using an allograft (Arthrex, Extra-Articular Augmentation device)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IKDC score
Time Frame: Month 8
Self-reported IKDC (International Knee Documentation Committee Subjective Knee Form) score, scaled between 0 and 100 (100 = good function)
Month 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IKDC score
Time Frame: Months 0, 2, 5, 12
Self-reported IKDC (International Knee Documentation Committee Subjective Knee Form) score, scaled between 0 and 100 (100 = good function)
Months 0, 2, 5, 12
Lysholm score
Time Frame: Months 0, 2, 5, 8, 12
The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting, scaled between 0 and 100 (100 = good function)
Months 0, 2, 5, 8, 12
SANE score
Time Frame: Months 0, 2, 5, 8, 12
The Single Numeric Assessment Evaluation is a subjective percentage of the knee functionality, scaled between 0% and 100% (100% = good function)
Months 0, 2, 5, 8, 12
Return-to-play
Time Frame: Months 5, 8, 12
Timing when return-to-play to full sports activities is possible
Months 5, 8, 12
Clinical evaluation: reverse pivot shift test
Time Frame: Months 0, 2, 5, 8, 12
Described as "Clunk absent", "Clunk present", or "Clunk present with shake"
Months 0, 2, 5, 8, 12
Clinical evaluation: anterior drawer test
Time Frame: Months 0, 2, 5, 8, 12
Described as "Hard stop", "Soft stop", or "Soft stop and increased course"
Months 0, 2, 5, 8, 12
Clinical evaluation: Lachman test
Time Frame: Months 0, 2, 5, 8, 12
Described as "Hard stop", "Soft stop", or "Soft stop and increased course"
Months 0, 2, 5, 8, 12
Clinical evaluation: thigh circumference 10 cm proximal to the patella
Time Frame: Months 0, 2, 5, 8, 12
measure in cm
Months 0, 2, 5, 8, 12
Clinical evaluation: thigh circumference 15 cm proximal to the patella
Time Frame: Months 0, 2, 5, 8, 12
measure in cm
Months 0, 2, 5, 8, 12
Clinical evaluation: knee extension
Time Frame: Months 0, 2, 5, 8, 12
Measured in °. Negative values associated with bad outcome
Months 0, 2, 5, 8, 12
Isokinetic test: knee extensors concentric strength
Time Frame: Months 5 & 8
Measured in absolute value and comparative value with controlateral limb
Months 5 & 8
Isokinetic test: knee flexors concentric strength
Time Frame: Months 5 & 8
Measured in absolute value and comparative value with controlateral limb
Months 5 & 8
Isokinetic test: knee flexors eccentric strength
Time Frame: Months 5 & 8
Measured in absolute value and comparative value with controlateral limb
Months 5 & 8
Rerupture rate
Time Frame: Year 3
Patients will be evaluated by phone at 3 years of follow-up. Rerupture of the ACL graft (yes-no) will be recorded.
Year 3

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographics: Age
Time Frame: Month 0
Age of the patient (years)
Month 0
Demographics: Sex
Time Frame: Month 0
Sex of the patient
Month 0
Demographics: timing between the trauma and the surgery
Time Frame: Month 0
Time in days
Month 0
Demographics: active tobacco use
Time Frame: Month 0
binary outcome (yes - no)
Month 0
Demographics: dyslipidemia
Time Frame: Month 0
binary outcome (yes - no)
Month 0
Demographics: past surgery of the knee
Time Frame: Month 0
binary outcome (yes - no)
Month 0
Demographics: Beighton score (joint hypermobility)
Time Frame: Month 0
graded from 0 (no joint hypermobility) to 9 (major joint hypermobility)
Month 0
Medial femorotibial chondropathy
Time Frame: Month 0
Graded from 0 to 4 on arthroscopy
Month 0
Lateral femorotibial chondropathy
Time Frame: Month 0
Graded from 0 to 4 on arthroscopy
Month 0
Femoropatellar chondropathy
Time Frame: Month 0
Graded from 0 to 4 on arthroscopy
Month 0
Internal lateral ligament tear
Time Frame: Month 0
Described as "absent", "partial", or "full" on MRI
Month 0
External lateral ligament tear
Time Frame: Month 0
Described as "absent", "partial", or "full" on MRI
Month 0
Internal meniscus lesion
Time Frame: Month 0
Described as "absent", "present, not repaired", or "present, repaired" on arthroscopy
Month 0
External meniscus lesion
Time Frame: Month 0
Described as "absent", "present, not repaired", or "present, repaired" on arthroscopy
Month 0
Surgical repair of the anterolateral ligament
Time Frame: Month 0
Described as "not performed", or "performed" during surgery
Month 0
Anterolateral ligament tear
Time Frame: Month 0
Described as "intact", "partial tear", "full teat" or "non evaluable on ultrasonography
Month 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adrien Schwitzguébel, MD, Hôpital de La Providence

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

April 30, 2020

First Submitted That Met QC Criteria

April 30, 2020

First Posted (Actual)

May 4, 2020

Study Record Updates

Last Update Posted (Actual)

September 23, 2021

Last Update Submitted That Met QC Criteria

September 17, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Rupture

Clinical Trials on ACL repair without anterolateral repair

3
Subscribe